Luminescent metal-organic framework films, CPM-5⊃Tb(3+) and MIL-100(In)⊃Tb(3+), have been constructed by postfunctionalization of two porous indium-organic frameworks with different structures, respectively. The MIL-100(In)⊃Tb(3+) film shows high oxygen sensitivity (KSV = 7.59) and short response/recovery time (6 s/53 s).
A positively charged porous drug carrier MOF-74-Fe(III) (1, MOF = metal-organic framework), which could not be directly synthesized using ferric salts, was prepared through the oxidation of the neutral crystal MOF-74-Fe(II). This cationic host material exhibits very low cytotoxicity upon PC12 cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay and high drug loading capacity of ibuprofen anions (∼15.9 wt %) through ion exchange and salt penetration procedures. Controlled by anion exchange, two mechanisms were involved in the drug release process with different drug delivery rates due to the presence of coordinated or free ibuprofen anions, making the administration of drug release more flexible.
A nanoscale MOF material NMOF 1 with controllable morphologies is realized whose morphology control has been simulated based on the BFDH method. The targeted NMOF 1 exhibits highly sensitive, selective and instant "turn-on" sensing of bacterial endospores.
Continuous and intergrown metal-organic framework (MOF) membranes, MIL-100(In) (MIL represents Materials Institute Lavoisier), were prepared directly on porous anodic alumina oxide (AAO) membranes using an in situ crystallization method. The pore surface of MIL-100(In) is conferred with polarity due to the presence of the 1,3,5-benzenetricarboxylic acid. The thickness of MIL-100(In)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.